Cite
Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells.
MLA
Cui, Qingbin, et al. “Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-Glycoprotein Overexpressing Cancer Cells.” International Journal of Molecular Sciences, vol. 20, no. 17, Sept. 2019, p. 4095. EBSCOhost, https://doi.org/10.3390/ijms20174095.
APA
Cui, Q., Cai, C.-Y., Wang, J.-Q., Zhang, S., Gupta, P., Ji, N., Yang, Y., Dong, X., Yang, D.-H., & Chen, Z.-S. (2019). Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells. International Journal of Molecular Sciences, 20(17), 4095. https://doi.org/10.3390/ijms20174095
Chicago
Cui, Qingbin, Chao-Yun Cai, Jing-Quan Wang, Shuang Zhang, Pranav Gupta, Ning Ji, Yuqi Yang, Xingduo Dong, Dong-Hua Yang, and Zhe-Sheng Chen. 2019. “Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-Glycoprotein Overexpressing Cancer Cells.” International Journal of Molecular Sciences 20 (17): 4095. doi:10.3390/ijms20174095.